Implementation of the Oxygen Saturation Index as a Predictor of Outcome in Prenatally Diagnosed CDH Neonates in the First 24 Hours of Life
Pediatric Pulmonology · 2025-01 · 60 (1)
DOI: 10.1002/ppul.27447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 17.12.2024. Verfasst von Lennart Hale und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Hernias, Diaphragmatic, Congenital, Oxygen Saturation, Oxygen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Aims
This study aimed to evaluate the Oxygen Saturation Index (OSI) as a noninvasive measure for early postnatal management and outcome prediction in neonates with congenital diaphragmatic hernia (CDH). Additionally, the study analyzed the correlation and predictive ability of OSI, Oxygenation Index (OI), Horovitz Index (HI), and partial pressure of arterial oxygen (PaO 2 ) regarding mortality and the need for extracorporeal membrane oxygenation (ECMO).
Methods
A retrospective, single‐center study using data from 2013 to 2020. Parameters for calculating indices were extracted from patient charts every hour during the first 24 h of life. Statistical analyses included ROC analysis for predictive cut‐off values and Spearman's rank for correlation assessments.
Results
The study included 138 neonates. Postductal OSI demonstrated high sensitivity (80%–85%) and negative predictive value (NPV) for predicting mortality and ECMO need, with cut‐off values between 11.5 and 13. Optimal cut‐off values for predicting ECMO need were 10 at 12 and 24 h (sensitivity 96.7%). OSI, OI, HI, and PaO 2 showed comparable predictive capabilities with strong correlations. The lowest OI of 18 predicted mortality with a sensitivity of 75% and specificity of 90.9%. Strong correlations were found between the lowest PaO 2 and lowest HI (0.963–0.974), and between highest OI and lowest PaO 2 (−0.922 to −0.945).
Conclusion
OSI is a promising index for predicting outcomes in CDH neonates, showing strong correlation with indices like OI and HI. Despite limitations, OSI provides continuous, bedside monitoring without invasive blood sampling. Further prospective studies are needed to validate these findings and establish new cut‐off values.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.
- Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
- Department of Obstetrics and Prenatal Medicine, University Hospital Cologne, Cologne, Germany.
ORCID-Profile: Florian Kipfmueller
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Hale, L., Leyens, J., Bo, B., Engel, C., Berg, C., Schroeder, L., Mueller, A., & Kipfmueller, F. (2025). Implementation of the Oxygen Saturation Index as a Predictor of Outcome in Prenatally Diagnosed CDH Neonates in the First 24 Hours of Life. Pediatric Pulmonology, 60(1). https://doi.org/10.1002/ppul.27447
Vancouver
Hale L, Leyens J, Bo B, Engel C, Berg C, Schroeder L, et al. Implementation of the Oxygen Saturation Index as a Predictor of Outcome in Prenatally Diagnosed CDH Neonates in the First 24 Hours of Life. Pediatric Pulmonology. 2025;60(1). doi:10.1002/ppul.27447
BibTeX
@article{Hale2025,
author = {Hale, Lennart and Leyens, Judith and Bo, Bartolomeo and Engel, Clara and Berg, Christoph and Schroeder, Lukas and Mueller, Andreas and Kipfmueller, Florian},
title = {Implementation of the Oxygen Saturation Index as a Predictor of Outcome in Prenatally Diagnosed CDH Neonates in the First 24 Hours of Life},
journal = {Pediatric Pulmonology},
year = {2025},
volume = {60},
number = {1},
doi = {10.1002/ppul.27447}
}
EUVIMED